Registration, quality assurance and the shape of a medicines contract
A medicines tender is decided on quality assurance before it is decided on price. Bidders must show that the product is authorised or registered for use in the destination market, that it is manufactured at a site holding current good manufacturing practice certification, and -- for many donor-funded and essential medicines programmes -- that the product or its manufacturer appears on a recognised prequalification list. These are documentary conditions of admissibility assessed against the specific product and manufacturing site offered, and a change of site after award is a contractual event, not an administrative one.
Products are specified by international non-proprietary name, strength and dosage form so that generics compete openly, with pharmacopoeial standards cited for quality. Delivery conditions carry as much weight as the product: a minimum proportion of shelf life remaining on arrival, batch certificates of analysis, tamper-evident and correctly labelled packaging in the required language, and unbroken cold chain with temperature monitoring for products that need it. A consignment that arrives with too little shelf life left is routinely rejected at the buyer's cost to the supplier.
The commercial structure is usually a framework at agreed unit prices with call-offs against forecast rather than firm volume, because demand depends on disease patterns and programme funding. That places emphasis on lead times, on the supplier's obligation to hold or replenish stock, and on what happens in a shortage -- allocation, substitution and notification terms are increasingly explicit. Recall capability is tested rather than assumed: buyers ask how quickly a batch can be traced and withdrawn from every facility it reached.
This section describes how this category is bought generally, across the public buyers that publish it. The figures elsewhere on this page are measured for this market alone.
Who buys pharmaceuticals in Switzerland?
GlobalGov holds 78 pharmaceuticals records from 48 distinct buying organisations in Switzerland. The most frequent publishers are IWB Industrielle Werke Basel (7 records); Achats du groupe Biens de consommation (4 records); Stadt Zürich Entsorgung + Recycling Zürich (4 records); Centrale d'achats et d'ingénierie biomédicale Vaud-Genève (CAIB) (3 records); Commune de Lausanne, Direction de la sécurité et de l'économie, Service de l'eau, Station d'épuration des eaux usées (3 records); Direction Droit, Achats et RIsques Unité Achats TAM (3 records). Between them the 6 largest account for 31% of everything published, so buying here is spread across many separate authorities.
| Buying organisation | Records | Share |
|---|---|---|
| IWB Industrielle Werke Basel | 7 | 9.0% |
| Achats du groupe Biens de consommation | 4 | 5.1% |
| Stadt Zürich Entsorgung + Recycling Zürich | 4 | 5.1% |
| Centrale d'achats et d'ingénierie biomédicale Vaud-Genève (CAIB) | 3 | 3.8% |
| Commune de Lausanne, Direction de la sécurité et de l'économie, Service de l'eau, Station d'épuration des eaux usées | 3 | 3.8% |
| Direction Droit, Achats et RIsques Unité Achats TAM | 3 | 3.8% |
How long do bidders get to respond to pharmaceuticals tenders in Switzerland?
Across the 36 Switzerland pharmaceuticals notices that publish both a publication date and a closing date, the median response window is 42 days. A quarter of them allowed 39 days or fewer and a quarter stayed open for more than 48. Not one of them closed within a fortnight of being published, so the window on this market is consistently workable.
How often are pharmaceuticals tenders published in Switzerland?
Switzerland published 8 notices in this category in the last twelve months. Over the last three years there were 39, spread across 41 separate months of activity since 2 April 2021. March is historically the busiest month. The most recent was published 27 July 2026.
How does Switzerland compare with other pharmaceuticals markets?
Among the 39 countries where GlobalGov holds a comparable pharmaceuticals market, Switzerland ranks 33rd by number of records. The largest is Germany (4,115 records against 78 here). Within Switzerland itself, pharmaceuticals is the 33rd largest of the 56 procurement categories tracked here.
Where do the Switzerland pharmaceuticals records on this page come from?
These 78 records are collected from 2 official sources: TED (76), UN Global Marketplace (2). GlobalGov is an independent aggregator and is not affiliated with any of them; each record links back to the notice on its issuing portal. The set is rebuilt nightly, and the counts on this page were taken on 2026-10-01.
Most recent Pharmaceuticals tenders in Switzerland
None of these are open for bids now — they are the most recent records GlobalGov holds for this market, kept here so the shape of a typical pharmaceuticals notice in Switzerland is visible. Set an alert to be told when the next one opens.
Long-Term Agreement for Traditional, Complementary and Integrative Medicine (TCIM) Policy Analysis, Stakeholder Engagement and Strategic Initiative Development [WHO-SHQ-GTMC-RFP-26-3019-LTA]
Switzerland – Social work and related services – Deutsch-Integrationskurse für fremdsprachige Erwachsene und Jugendliche ab 16 Jahren
Switzerland – Social work and related services – Bedarfsabklärungsstelle für Menschen mit Behinderung in den Kantonen LU/ZG
Switzerland-Le Lignon: Activated carbon
Other procurement categories in Switzerland
Pharmaceuticals procurement in other markets
Never Miss a Switzerland Government Contract
Finding Switzerland tenders usually means a local portal, a local registration and someone who reads the language. Get an alert you can read when a new pharmaceuticals opportunity is published there.
Start Free Trial